Short answer
RET codons 609, 611, 618, and 620 are cysteine-rich region variants that often come up in MEN2A and familial medullary thyroid cancer discussions. The codon number alone is not enough for management. You need the exact protein change, whether the result is germline or tumor-only, the classification, and the family history.
How to interpret the codon group
| Finding | Common next question | Why it matters |
|---|---|---|
| Germline RET 609/611/618/620 | What exact protein change was reported? | The codon group is not enough for management decisions. |
| Known family variant | Is targeted testing being used for relatives? | Cascade testing should match the exact familial variant. |
| Variant of uncertain significance | Was it handled differently from a pathogenic variant? | Uncertain variants should not drive irreversible decisions alone. |
GeneReviews, NCI, and MedlinePlus all describe RET as the key gene in MEN2-related inherited risk. The practical job of the report is to say whether this is a clearly pathogenic familial result, a targeted family test, or a less certain report that needs more context.
Why exact notation matters
Codon labels are convenient for conversation, but they can hide details that matter. A report may list C609, C611, C618, or C620, but the exact amino acid change, sample type, and classification determine whether the result is suitable for family testing and endocrine follow-up.
That is especially important when the report is being used to guide thyroid planning, pediatric timing, or whether relatives should be offered targeted testing.
What the result can change
- Whether the family has a clearly actionable MEN2A or FMTC result
- Whether children or siblings need targeted cascade testing
- Whether endocrine follow-up should be coordinated sooner
- Whether a VUS should be treated as unresolved rather than actionable
NCI's childhood MEN2 guidance makes it clear that early detection can affect management. That means the exact report language matters before anyone assumes the codon label alone is enough.
When family history changes the next step
Follow-up matters more when the codon group is being used to decide who in the family should be tested first, how urgent MEN2 planning is, or whether the report should be read as a targeted family result. Genetics counseling helps convert the codon name into a concrete plan.
When specialist review matters
Specialist review matters when codon language is being used to decide who in the family should be tested first or how urgent MEN2 planning is.
How genetic testing is done
Genetic testing is usually done with blood or saliva, and the lab workflow depends on whether the question is a targeted variant, a panel, or confirmation after a clinical finding. Genetics counseling can help clarify whether the next step is a new test, family testing, or a different clinical workup.
Questions to ask
- Does the report list a full protein notation such as p.Cys618Arg?
- Was this blood or saliva germline testing, tumor-only testing, or paired tumor-normal testing?
- Has a genetics professional explained MEN2A, familial medullary thyroid cancer, and the family plan?
- Who is coordinating thyroid, calcitonin, adrenal, parathyroid, and pediatric timing questions if relevant?
FAQ
What do RET codons 609, 611, 618, and 620 usually mean?
They usually refer to specific RET variants in the cysteine-rich region that are discussed in MEN2A and familial medullary thyroid cancer contexts. The codon number alone is not enough for management.
Why is exact notation important?
RET results should be read at the exact protein change level, such as p.Cys618Arg, because codon group language does not tell you the full classification, the sample type, or the family context.
Are codon 609, 611, 618, and 620 results the same risk?
No. Codon group language is a shortcut. The exact variant, family history, and report classification can change how the result is interpreted and what follow-up is appropriate.
Can a VUS at one of these codons drive major decisions?
Usually not by itself. A variant of uncertain significance should be handled differently from a clearly pathogenic germline RET result.
What does family testing need to match?
Family testing should target the known familial variant, not just the codon label. That is what makes cascade testing interpretable.
When should clinicians ask for more detail?
When the report only gives a codon number, when the sample type is unclear, or when the family plan still needs MEN2A or FMTC coordination.
Related guides: RET risk category interpretation, RET codon 918 MEN2B questions, RET C609Y and C618R report questions, and MEN2 family variant testing.